Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

ABBOTT LABORATORIES

(ABT)
  Report
Delayed Nyse  -  04:03 2022-09-23 pm EDT
100.68 USD   -0.39%
09/23Medical device makers see little impact from Fiona on Puerto Rico operations
RE
09/21NORTH AMERICAN MORNING BRIEFING : Caution to Dominate Ahead of Fed; Putin Dials Up Nuclear Threat
DJ
09/20US FDA Commits to Strengthening Infant Formula Supply
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Abbott Laboratories to Add 1,000 Jobs in Ireland in $450 Million Greenfield Plant Investment

08/12/2022 | 08:47am EDT


© MT Newswires 2022
Stocks mentioned in the article
ChangeLast1st jan.
ABBOTT LABORATORIES -0.39% 100.68 Delayed Quote.-28.46%
DONEGAL GROUP INC. -1.14% 13.85 Delayed Quote.-3.08%
All news about ABBOTT LABORATORIES
09/23Medical device makers see little impact from Fiona on Puerto Rico operations
RE
09/21NORTH AMERICAN MORNING BRIEFING : Caution to Dominate Ahead of Fed; Putin Dials Up Nuclear..
DJ
09/20US FDA Commits to Strengthening Infant Formula Supply
MT
09/17Late-Breaking Data Show Breadth of Abbott's Minimally Invasive Structural Heart Technol..
PR
09/17Late-Breaking Data Show Breadth of Abbott's Minimally Invasive Structural Heart Technol..
CI
09/16MARKETSCREENER'S WORLD PRESS REVIEW : September 16, 2022
MS
09/15ABBOTT LABORATORIES : Change in Directors or Principal Officers, Amendments to Articles of..
AQ
09/15Abbott Keeps Quarterly Dividend at $0.47 Per Share, Payable on Nov. 15 to Shareholders ..
MT
09/15Abbott Declares 395th Consecutive Quarterly Dividend
PR
09/15Abbott Declares Quarterly Common Dividend, Payable November 15, 2022
CI
More news
Analyst Recommendations on ABBOTT LABORATORIES
More recommendations
Financials (USD)
Sales 2022 42 514 M - -
Net income 2022 6 681 M - -
Net Debt 2022 6 183 M - -
P/E ratio 2022 26,6x
Yield 2022 1,86%
Capitalization 176 B 176 B -
EV / Sales 2022 4,29x
EV / Sales 2023 4,39x
Nbr of Employees 113 000
Free-Float 87,5%
Chart ABBOTT LABORATORIES
Duration : Period :
Abbott Laboratories Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ABBOTT LABORATORIES
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 22
Last Close Price 100,68 $
Average target price 124,89 $
Spread / Average Target 24,1%
EPS Revisions
Managers and Directors
Robert B. Ford Chairman, President, Chief Executive Officer & COO
Robert Emmett Funck Chief Financial Officer & Executive VP-Finance
Sabina Ewing Chief Investment Officer, VP-Business & Technology
Glenn Fletcher Tilton Independent Director
William A. Osborn Lead Independent Director
Sector and Competitors
1st jan.Capi. (M$)
ABBOTT LABORATORIES-28.46%176 313
MEDTRONIC PLC-20.10%109 868
BECTON, DICKINSON AND COMPANY-4.82%66 713
HOYA CORPORATION-17.56%35 356
DEXCOM, INC.-39.91%31 666
AMERISOURCEBERGEN CORPORATION3.24%28 436